Back
Capricor Therapeutics Stock Price Chart
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
47
CAPR
Capricor Therapeutics
Last Price:
13.24
Seasonality Move:
38.64%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAPR is experiencing selling pressure, which indicates risk of future bearish movement.
Capricor Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.24 | Sell |
| 20-day SMA: | 16.84 | Sell |
| 50-day SMA: | 18.44 | Sell |
| 200-day SMA: | 8.73 | Buy |
| 8-day EMA: | 14.73 | Sell |
| 20-day EMA: | 16.18 | Sell |
| 50-day EMA: | 16.02 | Sell |
| 200-day EMA: | 10.37 | Buy |
Capricor Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.14 | Sell |
| Relative Strength Index (14 RSI): | 35.05 | Sell |
| Chaikin Money Flow: | -1154257 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15 - 19.36) | Sell |
| Bollinger Bands (100): | (4.93 - 18.97) | Buy |
Capricor Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Capricor Therapeutics Stock
Is Capricor Therapeutics Stock a Buy?
- Capricor Therapeutics share price is 13.26 while CAPR 8-day simple moving average is 14.24, which is a Sell signal.
- The stock price of CAPR is 13.26 while Capricor Therapeutics 20-day SMA is 16.84, which makes it a Sell.
- Capricor Therapeutics 50-day simple moving average is 18.44 while CAPR share price is 13.26, making it a Sell technically.
- CAPR stock price is 13.26 and Capricor Therapeutics 200-day simple moving average is 8.73, creating a Buy signal.
CAPR Technical Analysis vs Fundamental Analysis
Sell
47
Capricor Therapeutics (CAPR)
is a Sell
Is Capricor Therapeutics a Buy or a Sell?
-
Capricor Therapeutics stock is rated a Sell
The current Capricor Therapeutics [CAPR] share price is $13.26. The Score for CAPR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Capricor Therapeutics Stock Info
Market Cap:
602.93M
Price in USD:
13.26
Share Volume:
1.28M
Capricor Therapeutics 52-Week Range
52-Week High:
23.40
52-Week Low:
3.52
Sell
47
Capricor Therapeutics (CAPR)
is a Sell
Capricor Therapeutics Share Price Forecast
-
What is the Capricor Therapeutics stock price today?
The Capricor Therapeutics stock price is 13.26 USD today. -
Will CAPR stock go up or go down?
Capricor Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Capricor Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics is overvalued.
Is Capricor Therapeutics Stock a Buy?
- Capricor Therapeutics share price is 13.26 while CAPR 8-day exponential moving average is 14.73, which is a Sell signal.
- The stock price of CAPR is 13.26 while Capricor Therapeutics 20-day EMA is 16.18, which makes it a Sell.
- Capricor Therapeutics 50-day exponential moving average is 16.02 while CAPR share price is 13.26, making it a Sell technically.
- CAPR stock price is 13.26 and Capricor Therapeutics 200-day simple moving average is 10.37, creating a Buy signal.
Fundamental Analysis of Capricor Therapeutics
Is Capricor Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.21 per share.
Technical Analysis of Capricor Therapeutics
Should I short Capricor Therapeutics stock?
- CAPR Moving Average Covergence Divergence (MACD) indicator is -1.14, suggesting Capricor Therapeutics is a Sell
- Capricor Therapeutics Relative Strength Index (RSI) is 35.05, which suggest Capricor Therapeutics is oversold
- The Bollinger Bands (25) for Capricor Therapeutics is (15 - 19.36), which suggest Capricor Therapeutics is a Buy
- The Bollinger Bands (100) for Capricor Therapeutics is (4.93 - 18.97), which suggest Capricor Therapeutics is a Buy
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.